Hakimeh  Akbari

Dr. Hakimeh Akbari


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2023 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
NSNader Salari
Nader Salari
HGHooman Ghasemi
Hooman Ghasemi
NANasrin Abdoli
Nasrin Abdoli
ARAdibeh Rahmani
Adibeh Rahmani
MSMohammad Hossain Shiri
Mohammad Hossain Shiri
Masoud MohammadiMasoud Mohammadi
Masoud Mohammadi
Background: Attention-Deficit / Hyperactivity Disorder is a developmental neurological disorder that has three basic characteristics: Attention Deficit, Hyperactivity, and impulsivity. This study aimed to investigate the prevalence of ADHD in children and adolescents. Methods: This investigation was carried out using the meta-analysis method under PRISMA guidelines. Until October 2020, the articles were gathered by scanning PubMed, Scopus, WOS, and Science Direct databases. The second version of Comprehensive Meta-Analysis software was used to run analyses after extracting data from chosen papers. At a significance level of 0.05, the I2 test was used to analyze study heterogeneity, and the Egger test was used to assess publication bias. Results: This analysis includes 61 cross-sectional research, with 53 research used to determine the prevalence of ADHD in children, 7.6% of 96,907 children aged 3 to 12 years had ADHD (95% confidence interval: 6.1–9.4%), and 5.6% of teenagers aged 12 to 18 years have ADHD (95% confidence interval: 4.8-7%). The prevalence of ADHD in children and adolescents according to the DSM-V criterion is also higher than previous diagnostic criteria, according to studies. Conclusion: The findings of this study based on meta-analysis show the high prevalence of attention deficit hyperactivity disorder (ADHD). The findings of this study demonstrate the importance of management and policy in the treatment and control of ADHD in children and adolescents.

24 May 2022 in Maternal and Child Health Journal
Verified
Journal Article
Closed access
PDF file
MKMohammadmahdi Karami
Mohammadmahdi Karami
MCMaryam Chaleshgar
Maryam Chaleshgar
NSNader Salari
Nader Salari
HAHakimeh Akbari
Hakimeh Akbari
Masoud MohammadiMasoud Mohammadi
Masoud Mohammadi

25 January 2012 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
PSParvin Salehinejad
Parvin Salehinejad
NANoorjahan Banu Alitheen
Noorjahan Banu Alitheen
AAAbdul Manaf Ali
Abdul Manaf Ali
AOAbdul Rahman Omar
Abdul Rahman Omar
MMMaryam Mohit
Maryam Mohit
SNSeyed Noureddin Nematollahi‑Mahani
Seyed Noureddin Nematollahi‑Mahani

1 September 2012 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
SKSaeid Karamouzian
Saeid Karamouzian
SNSeyed Noureddin Nematollahi‑Mahani
Seyed Noureddin Nematollahi‑Mahani
NNNozar Nakhaee
Nozar Nakhaee
HEHossein Eskandary
Hossein Eskandary

23 October 2022 in BioPsychoSocial Medicine
Verified
Journal Article
Open access
PDF file
NSNader Salari
Nader Salari
YKYassaman Khodayari
Yassaman Khodayari
AFAmin Hosseinian Far
Amin Hosseinian Far
HZHosna Zarei
Hosna Zarei
SRShabnam Rasoulpoor
Shabnam Rasoulpoor
Masoud MohammadiMasoud Mohammadi
Masoud Mohammadi
Background: Chronic fatigue syndrome is a persistent and debilitating disorder. According to several studies, chronic fatigue syndrome has been identified among recovered COVID-19 patients as the most common symptom of long COVID. The aim of this systematic review and meta-analysis study was to obtain the prevalence of chronic fatigue syndrome in long COVID cases. Methods: In this systematic review and meta-analysis, we analysed reported results of studies that assessed the occurrence of chronic fatigue syndrome among COVID-19 patients four weeks after the onset of symptoms. The study selection was commenced by searching PubMed, Web of Science, Science Direct, Scopus, Embase, and Google scholar using the keywords of Chronic fatigue syndrome, COVID-19, and post-COVID-19 syndrome. The searches were without a lower time limit and until April 2022. Heterogeneity of studies was assessed using the I2 index, and a random effects model was used for analysis. Data analysis was performed within the Comprehensive Meta-Analysis software (version 2). Results: The pooled prevalence of chronic fatigue syndrome four weeks after the onset of COVID-19 symptoms, in 52 studies with a sample size of 127,117, was 45.2% (95% CI: 34.1-56.9%). Meta-regression analysis in examining the effects of the two factors of sample size, and year of study on the changes in the overall prevalence, showed that with increasing sample size, and year of study, the prevalence of chronic fatigue syndrome among long COVID patients (p < 0.05). Conclusion: Our results show that the overall prevalence of chronic fatigue syndrome as a long COVID symptom is 45.2%. Chronic fatigue after infection with COVID-19 can negatively affect personal and social lives. Given such significant negative consequences caused by the syndrome, it is recommended that health policymakers allocate funds to reduce the adverse effects of this syndrome, by creating programs to support long COVID patients.

5 February 2022 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
NSNader Salari
Nader Salari
MKMohammad Mahdi Karami
Mohammad Mahdi Karami
SBShadi Bokaee
Shadi Bokaee
MCMaryam Chaleshgar
Maryam Chaleshgar
SSShamarina Shohaimi
Shamarina Shohaimi
Masoud MohammadiMasoud Mohammadi
Masoud Mohammadi
Background: Urinary tract infection is the most common infection in type 2 diabetic patients. Various studies have reported different outbreaks of urinary tract infections in type 2 diabetic patients. Therefore, the present study aimed to determine the prevalence of urinary tract infections in type 2 diabetic patients during a systematic review and meta-analysis in order to develop interventions to reduce the incidence of urinary tract infections in type 2 diabetic patients. Methods: In this study, systematic review and meta-analysis of study data related to the prevalence of urinary tract infection in type 2 diabetic patients were conducted using keywords including type 2 diabetes, urinary tract infection, diabetes, prevalence, meta-analysis and their English equivalents in SID, MagIran, IranMedex, IranDoc, Google Scholar, Cochrane, Embase, Science Direct, Scopus, PubMed and Web of Science (WoS) databases from 1993 to 2020. In order to perform the analysis of qualified studies, the model of random-effects was used, and the inconsistency of studies with the I2 index was investigated. Data analysis was performed with Comprehensive Meta-Analysis (Version 2). Results: Based on a total of 15 studies with a sample size of 827,948 in meta-analysis, the overall prevalence of urinary tract infection in patients with type 2 diabetes was 11.5% (95% confidence interval: 7.8–16.7%). The prevalence of urinary tract infections in diabetic Iranian patients increased with increasing number of years of research, (p < 0.05), and with increasing age of participants (p < 0.05), but however the prevalence decreased with increasing sample size (p < 0.05). Conclusion: This study shows that urinary tract infections are highly prevalent in patients with type 2 diabetes. Therefore, due to the growing prevalence of diabetes and its complications such as urinary tract infections, the need for appropriate screening programs and health care policies is becoming more apparent.